Ledger.Open graph →
SEC Form D · filed November 17, 2014

CORTEX PHARMACEUTICALS INC/DE/

Offering
$1.0M
Sold
$239K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLEN ROCK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Richard E. Purcell · Glen Rock, NJExecRobert N. Weingarten · Glen Rock, NJExec · DirectorKathryn E. Macfarlane · Glen Rock, NJDirectorArnold S. Lippa · Glen Rock, NJExec · DirectorJames E. Sapirstein · Glen Rock, NJDirectorJeff E. Margolis · Glen Rock, NJExec · DirectorGary W. Bender · Scottsdale, AZExecPhilip W. Treick · San Francisco, CADirectorRobert W. Mullin · San Francisco, CAExec · DirectorJames R. Keller · San Francisco, CADirectorKarl Loevenich · Bradenton, FLExec · DirectorChristine Day · Vancouver, British Columbia, CanadaDirectorNicole Agnew · Vancouver, British Columbia, CanadaExec · DirectorJeff E. Margolis · Glen Rock, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗